Lalu Manoj M, Richards Dawn, Foster Madison, French Brittany, Crawley Angela M, Fiest Kirsten M, Hendrick Kathryn, Macala Kimberly F, Mendelson Asher A, Messner Pat, Nicholls Stuart G, Presseau Justin, Séguin Cheryle A, Sullivan Patrick, Thébaud Bernard, Fergusson Dean A
Blueprint Translational Research Group, Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Regenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Res Involv Engagem. 2024 Feb 12;10(1):25. doi: 10.1186/s40900-024-00545-7.
Patient engagement in research is the meaningful and collaborative interaction between patients and researchers throughout the research process. Patient engagement can help to ensure patient-oriented values and perspectives are incorporated into the development, conduct, and dissemination of research. While patient engagement is increasingly prevalent in clinical research, it remains relatively unrealized in preclinical laboratory research. This may reflect the nature of preclinical research, in which routine interactions or engagement with patients may be less common. Our team of patient partners and researchers has previously identified few published examples of patient engagement in preclinical laboratory research, as well as a paucity of guidance on this topic. Here we propose the development of a process framework to facilitate patient engagement in preclinical laboratory research.
Our team, inclusive of researchers and patient partners, will develop a comprehensive, empirically-derived, and stakeholder-informed process framework for 'patient engagement in preclinical laboratory research.' First, our team will create a 'deliberative knowledge space' to conduct semi-structured discussions that will inform a draft framework for preclinical patient engagement. Over the course of several sessions, we will identify actions, activities, barriers, and enablers (e.g. considerations and motivations for patient engagement in preclinical laboratory research, define roles of key players). The resulting draft process framework will be further populated with examples and refined through an international consensus-building Delphi survey with patients, researchers, and other collaborator organizations. We will then conduct pilot field tests to evaluate the framework with preclinical laboratory research groups paired with patient partners. These results will be used to create a refined framework enriched with real-world examples and considerations. All resources developed will be made available through an online repository.
Our proposed process framework will provide guidance, best practices, and standardized procedures to promote patient engagement in preclinical laboratory research. Supporting and facilitating patient engagement in this setting presents an exciting new opportunity to help realize the important impact that patients can make.
患者参与研究是指患者与研究人员在整个研究过程中进行有意义的协作互动。患者参与有助于确保以患者为导向的价值观和观点融入研究的开展、实施及传播过程。虽然患者参与在临床研究中越来越普遍,但在临床前实验室研究中仍相对未得到充分实现。这可能反映了临床前研究的性质,即与患者的常规互动或参与可能不太常见。我们的患者合作伙伴和研究人员团队此前发现,已发表的临床前实验室研究中患者参与的实例很少,而且关于这一主题的指导也很匮乏。在此,我们提议制定一个流程框架,以促进患者参与临床前实验室研究。
我们的团队,包括研究人员和患者合作伙伴,将为“患者参与临床前实验室研究”制定一个全面的、基于实证的且有利益相关者参与的流程框架。首先,我们的团队将创建一个“审议知识空间”,进行半结构化讨论,为临床前患者参与的框架草案提供信息。在几次会议过程中,我们将确定行动、活动、障碍和促进因素(例如患者参与临床前实验室研究的考虑因素和动机,界定关键参与者的角色)。由此产生的流程框架草案将进一步充实实例,并通过与患者、研究人员和其他合作组织进行的国际共识建立德尔菲调查进行完善。然后,我们将进行试点实地测试,与配备患者合作伙伴的临床前实验室研究小组一起评估该框架。这些结果将用于创建一个充实了实际案例和考虑因素的完善框架。所开发的所有资源将通过在线知识库提供。
我们提议的流程框架将提供指导、最佳实践和标准化程序,以促进患者参与临床前实验室研究。在这种情况下支持和促进患者参与是一个令人兴奋的新机会,有助于实现患者能够产生的重要影响。